OTLK
Outlook TherapeuticsยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
OTLK fundamentals
Outlook Therapeutics (OTLK) released its earnings on Aug 14, 2025: revenue was 1.51M (YoY 0.00%), missed estimates; EPS was -0.55 (YoY +33.73%), missed estimates.
Revenue / YoY
1.51M
0.00%
EPS / YoY
-0.55
+33.73%
Report date
Aug 14, 2025
Earnings Call
4:00 PM on Aug 14, 2025
Meeting link.EPS
Revenue
Revenue & Expenses
OTLK has released its 2025 Q3 earnings report, with revenue of 1.51M, reflecting a YoY change of NaN%, and net profit of -20.15M, showing a YoY change of -145.38%. The Sankey diagram below clearly presents OTLK's revenue sources and cost distribution.
Key Indicators
Outlook Therapeutics (OTLK) key financial stats and ratios, covering profitability, financial health, and leverage.
Outlook Therapeutics (OTLK)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Outlook Therapeutics (OTLK)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Outlook Therapeutics (OTLK)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Outlook Therapeutics (OTLK) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Outlook Therapeutics (OTLK) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What is the revenue and EPS growth rate for Outlook Therapeutics year over year?What is Outlook Therapeutics's gross profit margin?What does Outlook Therapeutics do and what are its main business segments?Did Outlook Therapeutics beat or miss consensus estimates last quarter?What factors drove the changes in Outlook Therapeutics's revenue and profit?What is Outlook Therapeutics's latest dividend and current dividend yield?What guidance did Outlook Therapeutics's management provide for the next earnings period?What is the market's earnings forecast for Outlook Therapeutics next quarter?
